Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

News & Events

Latest news and events related to our activities and our portfolio partners.
  • Xeraya Admin
  • Posted by Xeraya Admin
March 29, 2018
2 min read

Indian Oil to buy 4% stake in LanzaTech

  • Xeraya Admin
  • Posted by Xeraya Admin
March 26, 2018
2 min read

Beating out market leaders in PhII, antibiotic-maker Allecra readies for Phase III trials

  • Xeraya Admin
  • Posted by Xeraya Admin
March 8, 2018
5 min read

Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR

  • Xeraya Admin
  • Posted by Xeraya Admin
February 16, 2018
3 min read

Allecra Therapeutics Announces Fast Track Designation for Lead Antibiotic in Resistant Infections

  • Xeraya Admin
  • Posted by Xeraya Admin
February 6, 2018
3 min read

Liquidia Technologies Appoints Kevin Gordon as President and Chief Financial Officer

  • Xeraya Admin
  • Posted by Xeraya Admin
December 4, 2017
3 min read

Allecra Therapeutics Announces New Staged Financing Deal to Take the Company Through to End of Phase 3

  • Xeraya Admin
  • Posted by Xeraya Admin
November 10, 2017
3 min read

Washington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System from ViewRay

  • Xeraya Admin
  • Posted by Xeraya Admin
November 6, 2017
4 min read

Chemical & Engineering News has featured P2 Science as one of the 10 Chemistry Startups to watch in 2017

  • Xeraya Admin
  • Posted by Xeraya Admin
November 3, 2017
2 min read

ViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender

  • Xeraya Admin
  • Posted by Xeraya Admin
October 25, 2017
5 min read

Ambu Announces Acquisition of Invendo Medical GmbH

  • Xeraya Admin
  • Posted by Xeraya Admin
October 24, 2017
5 min read

ViewRay Raises $50 Million through Sale of Common Stock

  • Xeraya Admin
  • Posted by Xeraya Admin
October 24, 2017
6 min read

Acutus Medical Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias

  • Xeraya Admin
  • Posted by Xeraya Admin
October 18, 2017
2 min read

FDA clears OptiScan’s automated bedside glucose monitoring system

  • Xeraya Admin
  • Posted by Xeraya Admin
April 6, 2017
3 min read

Iconic Therapeutics appoints Julia P. Gregory to Board of Directors

  • Xeraya Admin
  • Posted by Xeraya Admin
March 1, 2017
2 min read

P2 Science Raises $9.55 Million in Series B Financing Round

  • Xeraya Admin
  • Posted by Xeraya Admin
February 27, 2017
4 min read

ViewRay Receives FDA 510(k) Clearance for MRIdianLinac announces Fourth Quarter and Full Year 2016 Financial Highlights , including Record Revenue and $133.2 million in Backlog.

  • Xeraya Admin
  • Posted by Xeraya Admin
February 9, 2017
2 min read

Iconic Therapeutics to Present Phase 2a Emerge Trial Results at Miami Meeting

  • Xeraya Admin
  • Posted by Xeraya Admin
September 7, 2016
6 min read

Invendo medical Announces FDA Clearance of the invendoscopy E200 System Including the First and Only Sterile , Single – use Endoscope For Colonoscopies

  • Xeraya Admin
  • Posted by Xeraya Admin
August 9, 2016
2 min read

Iconic Therapeutics Announces Final Close Of Series C Financing With Additional $10 Million Investment

  • Xeraya Admin
  • Posted by Xeraya Admin
March 22, 2016
3 min read

Acutus Medical Completes $75 Million Series C Financing

  • Xeraya Admin
  • Posted by Xeraya Admin
December 8, 2015
2 min read

Dr Ivor Royston agrees to join ViroPro’s Board of Directors

  • Xeraya Admin
  • Posted by Xeraya Admin
October 13, 2015
3 min read

ViewRay Receives 2015 Frost & Sullivan Technology Innovation Leadership Award

  • Xeraya Admin
  • Posted by Xeraya Admin
August 18, 2015
1 min read

Sentinext recognized at BioMalaysia 2015

  • Xeraya Admin
  • Posted by Xeraya Admin
July 23, 2015
2 min read

ViewRay completes Alternative Public Offering on US Exchange